These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26394731)

  • 1. Refractory Graves' Disease Successfully Cured by Adjunctive Cholestyramine and Subsequent Total Thyroidectomy.
    Yang Y; Hwang S; Kim M; Lim Y; Kim MH; Lee S; Lim DJ; Kang MI; Cha BY
    Endocrinol Metab (Seoul); 2015 Dec; 30(4):620-5. PubMed ID: 26394731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The surgical treatment of Graves' disease].
    de Ruijter SH; van Dalen T; Muller AF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
    Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
    J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of treatment options for Graves' disease: why total thyroidectomy is a viable option in selected patients.
    Mohan V; Lind R
    J Community Hosp Intern Med Perspect; 2016; 6(4):32369. PubMed ID: 27609732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid preoperative blockage of thyroid hormone production / secretion in patients with Graves' disease.
    Fischli S; Lucchini B; Müller W; Slahor L; Henzen C
    Swiss Med Wkly; 2016; 146():w14243. PubMed ID: 26765838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithyroid Drugs in the Management of Graves' Disease: A Friend and Foe.
    Butt MI; Riazuddin M; Joueidi F; Waheed N
    Cureus; 2023 Mar; 15(3):e36028. PubMed ID: 37050997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dramatic response to cholestyramine in a patient with Graves' disease resistant to conventional therapy.
    Sebastián-Ochoa A; Quesada-Charneco M; Fernández-García D; Reyes-García R; Rozas-Moreno P; Escobar-Jiménez F
    Thyroid; 2008 Oct; 18(10):1115-7. PubMed ID: 18816181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium as an alternative option in thionamide-resistant Graves' disease.
    Chung YK; Wong LM
    Clin Pediatr Endocrinol; 2023; 32(3):168-173. PubMed ID: 37362160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid cancer in Graves' disease: is surgery the best treatment for Graves' disease?
    Tamatea JA; Tu'akoi K; Conaglen JV; Elston MS; Meyer-Rochow GY
    ANZ J Surg; 2014 Apr; 84(4):231-4. PubMed ID: 22985335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbimazole-Resistant Graves' Disease Responding to Oral Prednisolone: A Case Report.
    Kamrul-Hasan AB; Mondal E
    Mymensingh Med J; 2022 Apr; 31(2):553-555. PubMed ID: 35383779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative management of the thyrotoxic patient.
    Langley RW; Burch HB
    Endocrinol Metab Clin North Am; 2003 Jun; 32(2):519-34. PubMed ID: 12800544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive cholestyramine therapy for thyrotoxicosis.
    Solomon BL; Wartofsky L; Burman KD
    Clin Endocrinol (Oxf); 1993 Jan; 38(1):39-43. PubMed ID: 8435884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.
    Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J
    J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of Graves disease.
    Streetman DD; Khanderia U
    Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of Graves' disease patients treated in a region with iodine deficiency: relapse rate increases in years with thionamides.
    Tütüncü NB; Tütüncü T; Ozgen A; Erbas T
    J Natl Med Assoc; 2006 Jun; 98(6):926-30. PubMed ID: 16775915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare Presentation of Thyrotoxicosis Defying Methimazole Treatment: A Case Series.
    Renzu M; Mehta V; Qazi A; Satei AM; Taha W
    Cureus; 2024 Apr; 16(4):e58980. PubMed ID: 38800321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent Graves' Disease Following Near-Total Thyroidectomy: A Case Report and Literature Review.
    Menon LP; Naqvi S; Maradana J; Edem D
    Cureus; 2024 Jan; 16(1):e52260. PubMed ID: 38352081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.